Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Dupuy

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
American Journal of Hypertension|August 2, 2000
Efficacy of rilmenidine, a selective I1 imidazoline receptor binding agent in diabetic hypertensive patientsO Dupuy, B Bauduceau, H Mayaudon
Journal of Cardiovascular Risk|April 29, 2000
Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captoprilB Bauduceau, H Mayaudon, O Dupuy
Cardiovascular Drugs and Therapy|February 25, 2000
Efficacy of rilmenidine versus captopril on microalbuminuria: a pilot study in hypertensive type 2 diabeticsB Bauduceau, H Mayaudon, O Dupuy
American Journal of Optometry and Physiological Optics|May 1, 1974
Eye-protectors: contribution to the study of prismatic powerO Dupuy, G Roger, S Slansky
Presse Medicale (Paris, France : 1983)|October 19, 2000
[Absolute cardiovascular risk in diabetes]H Mayaudon, O Dupuy, L Bordier, et al.
International Journal of Sports Medicine|June 15, 2010
Effect of functional overreaching on executive functionsO Dupuy, M Renaud, L Bherer, et al.
Diabetes & Metabolism|May 29, 2020
Septic shock with methicillin-sensitive Staphylococcus aureus secondary to continuous subcutaneous insulin infusion by external pumpA Ben Hamou, O Maurou, S Nadler, et al.
La Revue De Medecine Interne|January 1, 1996
[Hemophagocytic syndromes]A Fléchaire, B Colle, P Bernard, et al.
La Revue De Medecine Interne|May 1, 1993
[Hepatocellular insufficiency and pseudo-surgical abdominal pain in adult onset Still disease]O Dupuy, S Benefice, Y Martin, et al.
Diabetes & Metabolism|March 10, 2001
[Calculation of the absolute cardiovascular risk in practice]H Mayaudon, O Dupuy, L Bordier, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
American Journal of Hypertension|August 2, 2000
Efficacy of rilmenidine, a selective I1 imidazoline receptor binding agent in diabetic hypertensive patientsO Dupuy, B Bauduceau, H Mayaudon
Journal of Cardiovascular Risk|April 29, 2000
Rilmenidine in the hypertensive type-2 diabetic: a controlled pilot study versus captoprilB Bauduceau, H Mayaudon, O Dupuy
Cardiovascular Drugs and Therapy|February 25, 2000
Efficacy of rilmenidine versus captopril on microalbuminuria: a pilot study in hypertensive type 2 diabeticsB Bauduceau, H Mayaudon, O Dupuy
American Journal of Optometry and Physiological Optics|May 1, 1974
Eye-protectors: contribution to the study of prismatic powerO Dupuy, G Roger, S Slansky
Presse Medicale (Paris, France : 1983)|October 19, 2000
[Absolute cardiovascular risk in diabetes]H Mayaudon, O Dupuy, L Bordier, et al.
International Journal of Sports Medicine|June 15, 2010
Effect of functional overreaching on executive functionsO Dupuy, M Renaud, L Bherer, et al.
Diabetes & Metabolism|May 29, 2020
Septic shock with methicillin-sensitive Staphylococcus aureus secondary to continuous subcutaneous insulin infusion by external pumpA Ben Hamou, O Maurou, S Nadler, et al.
La Revue De Medecine Interne|January 1, 1996
[Hemophagocytic syndromes]A Fléchaire, B Colle, P Bernard, et al.
La Revue De Medecine Interne|May 1, 1993
[Hepatocellular insufficiency and pseudo-surgical abdominal pain in adult onset Still disease]O Dupuy, S Benefice, Y Martin, et al.
Diabetes & Metabolism|March 10, 2001
[Calculation of the absolute cardiovascular risk in practice]H Mayaudon, O Dupuy, L Bordier, et al.
Pageof 9